Health Catalyst, Inc. — Director's Dealing 2021

Aug 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-08-10

Reporting Person: Hinton Bryan Richard (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-10	Common Stock	M	528.00	$10.78	Acquired	24595.00	Direct
2021-08-10	Common Stock	M	1300.00	$10.80	Acquired	25895.00	Direct
2021-08-10	Common Stock	S	658.00	$52.9077	Disposed	25237.00	Direct
2021-08-10	Common Stock	S	1310.00	$54.0233	Disposed	23927.00	Direct
2021-08-10	Common Stock	S	1327.00	$54.6493	Disposed	22600.00	Direct
2021-08-10	Common Stock	S	725.00	$55.5114	Disposed	21875.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-10	Stock Option (Right to Buy)	$10.80	M	1300.00	Disposed	2028-09-27	Common Stock (1300.00)	Direct
2021-08-10	Stock Option (Right to Buy)	$10.78	M	528.00	Disposed	2028-05-03	Common Stock (528.00)	Direct

Footnotes

F1: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1.

F2: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $52.28 to $53.13, inclusive.

F3: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.47 to $54.38, inclusive.

F4: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $54.48 to $54.82, inclusive.

F5: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $55.51 to $55.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (5).

F6: 25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.

F7: 25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022.